(Q34009204)

30 July 2017

1 reference

title

The importance of quality-of-life endpoints in clinical trials to the practicing oncologist (English)

1 reference

30 July 2017

1 reference

Passik SD

1

1 reference

30 July 2017

Kirsh KL

series ordinal

2

1 reference

30 July 2017

publication date

1 August 2000

1 reference

Hematology / Oncology Clinics of North America

30 July 2017

published in

1 reference

30 July 2017

volume

14

1 reference

30 July 2017

issue

4

1 reference

30 July 2017

page(s)

877-886

1 reference

Depressive reactions to lung cancer are common and often followed by a poor outcome

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970316-6

7 January 2021

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970316-6

7 January 2021

The Functional Assessment of Cancer Therapy scale: development and validation of the general measure

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970316-6

7 January 2021

Communicating with patients about advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970316-6

7 January 2021

Oncologists' recognition of depression in their patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970316-6

7 January 2021

The changeable nature of patients' fears regarding chemotherapy: implications for palliative care

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970316-6

7 January 2021

The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970316-6

7 January 2021

An investigational new drug treatment program for patients with gemcitabine: results for over 3000 patients with pancreatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970316-6

7 January 2021

A model for psychosocial phasing in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970316-6

7 January 2021

The existential plight in cancer: significance of the first 100 days

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970316-6

7 January 2021

Quality of life in adult bone marrow transplant patients: beyond the first year

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970316-6

7 January 2021

Mitoxantrone. A review of its pharmacology and clinical efficacy in the management of hormone-resistant advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970316-6

7 January 2021

Someone to live for: social well-being, parenthood status, and decision-making in oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970316-6

7 January 2021

10.1016/S0889-8588(05)70316-6

Identifiers

DOI

1 reference

30 July 2017

1 reference